baber/WOPTO huggingface dataset:
Patent JP-2001503178-A (JP)
Title: データベースアクセスシステム
IPC: G06F21/84
Filed: 1998-04-21
Abstract: (57)【要約】
電子ネットワーク上で配信されるデータベースへのアクセスを編成するための本方法は、専用サーバー上にシステムサイトを含んでいる。ユーザーは、システムサイト上に記憶されている電子ネットワーク上の承認されたデータベースサイトへのアドレスのリストに、ブラウザアプリケーションを使ってアクセスする。参照カードを使えば、ユーザーは承認されたサイトのリストを探してレビューすることができる。第１の好適な実施例では、データベースサイトへのアクセスの要求は専用サーバーに対して行われる。承認されていないサイトへのアクセスは拒否される。承認されたデータベースは専用サーバーによって検索される。承認されたサイトへの各データベースリンクは、将来の全てのアクセスが専用サーバーを通して行われるようにするため、直接から間接へと変更される。承認されたサイトのリストにないリンクはアクセスが拒否されることになる。第２の、同等に好適な実施例では、データベース位置を定義するコードが、承認されていないデータベースサイトへのリンクを非活動状態とするため、専用サーバーで除去される。非活動状態とされたリンクを表すワードからは、前の電子ネットワークリンクを表すあらゆる兆候が消去される。本発明の第３の実施例では、フレーム調整されたスクリーンディスプレイは、ユーザーが電子ネットワークへの独立したアクセスのための位置を定義しないようにするため、ブラウサアプリケーションディスプレイを無効にする。電子ネットワークへのアクセスは専用サーバーを通してのみ行われ、これにより、ユーザーがアクセスできるのは承認されたサイトに制限される。
Patent JP-2000510485-A (JP)
Title: 性的機能障害治療用の５型サイクリックグアノシン３′，５′−一リン酸ホスホジエステラーゼ（ｃＧＭＰ  ＰＤＥ５）を阻害するピラゾロピリミジノン類
IPC: A61P9/00
Filed: 1998-04-10
Abstract: (57)【要約】
式（ＩＡ）および（ＩＢ）(式中、Ｒ 1 は、Ｃ 1 〜Ｃ 3 アルキルであって、Ｃ 3 〜Ｃ 6 シクロアルキル、ＣＯＮＲ 5 Ｒ 6 またはＮ−結合複素環式基で置換されたもの;（ＣＨ 2 ） n Ｈｅｔまたは（ＣＨ 2 ） n Ａｒであり：Ｒ 2 はＣ 1 〜Ｃ 6 アルキルであり；Ｒ 3 は、Ｃ 1 〜Ｃ 4 アルコキシで置換されていてよいＣ 1 〜Ｃ 6 アルキルであり；Ｒ 4 はＳＯ 2 ＮＲ 7 Ｒ 8 であり；Ｒ 5 およびＲ 6 は、それぞれ独立して、Ｈおよび、Ｃ 1 〜Ｃ 4 アルコキシで置換されていてよいＣ 1 〜Ｃ 4 アルキルより選択され、またはそれらが結合している窒素原子と一緒になって、５員または６員複素環式基を形成し；Ｒ 7 およびＲ 8 は、それらが結合している窒素原子と一緒になって４−Ｒ 10 −ピペラジニル基を形成し；Ｒ 10 は、Ｈ、またはＯＨ、Ｃ 1 〜Ｃ 4 アルコキシ若しくはＣＯＮＨ 2 で置換されていてよいＣ 1 〜Ｃ 4 アルキルであり；Ｈｅｔは、置換されていてよいＣ−結合５員または６員複素環式基であり；Ａｒは、置換されていてよいフェニルであり；そしてｎは０または１である)を有する化合物またはその薬学的に若しくは獣医学的に許容しうる塩、またはそれらの薬学的に若しくは獣医学的に許容しうる溶媒和化合物は、特に、雄性勃起機能障害および雌性性的機能障害の治療において有用な強力且つ選択的ｃＧＭＰ  ＰＤＥ５阻害剤である。
Patent JP-2002501660-A (JP)
Title: ディスプレイ用のデバイス及びその方法
IPC: H05B33/26
Filed: 1998-04-30
Abstract: (57)【要約】
エレクトロルミネセント・ディスプレイは、蛍光体が形成されたエリア上に導体ストリップを有している。本発明の一観点は、第１の導体に接続されている第１の導体バスと第２の導体に接続されている第２の導体バスとを支持する誘電体キャリアを含んでいるデバイスに向けられている。第１及び第２の導体は相互に近接配置されて、これらの間に蛍光体ベースのキャリアが配置され、蛍光体から光を発生するように第１及び第２の導体に供給された電圧によって、電界がセットアップされるよう構成されている。
Patent JP-2001523427-A (JP)
Title: パワー管理機能を有するハンドヘルドセルラ電話
IPC: H04B7/005
Filed: 1998-04-22
Abstract: (57)【要約】
ハンドヘルドモードで作動させられるときに電池パワーを節約して使うために、移動無線電話の最大送信パワーを制限するパワー制御論理回路を含む移動端末。この移動無線電話は、基地局から受信されるパワー制御コードに応答して送信パワーをセットするパワー制御論理回路を含む。基地局から送信されるパワー制御コードは指定されたパワーレベルに対応する。移動無線電話がハンドヘルドモードで作動させられているかどうかを指示するために、１つの信号が生成される。移動無線電話がハンドヘルドモードで作動させられるときは、パワー制御論理回路がパワーレベルを、最大送信パワーレベルよりも小さい最大ハンドヘルドパワーレベルへセットする。
Patent JP-2001524128-A (JP)
Title: キナゾリン系化合物によりセリン／トレオニン蛋白質キナーゼ機能を調節する方法
IPC: A61P43/00
Filed: 1998-05-01
Abstract: (57)【要約】
本発明は、部分的には、キナゾリン系化合物によりセリン／トレオニン蛋白質キナーゼの機能を調節する方法に関する。該方法は、セリン／トレオニン蛋白質キナーゼ、例えばＲＡＦを発現する細胞を組み込む。さらに、本発明は、生物において、セリン／トレオニン蛋白質キナーゼに関連する異常な状態を、本発明により同定される化合物を用いて予防および治療する方法を記載する。さらに、本発明はこれらの化合物を含むキナゾリン化合物および医薬組成物に関する。
Patent JP-2000515412-A (JP)
Title: 流体成分を分離する管セット、装置および方法
IPC: A61M1/36
Filed: 1998-05-07
Abstract: (57)【要約】
流体の成分または粒子を分離する装置および方法を提供する。バリア堰を有する分離容器を設けて、最初に流体の中間密度の成分を分離し、流体チャンバを設けて、水簸の場または飽和流動粒子床を形成することによって、中間密度の成分をさらに分離する。分離容器は、遠心器回転体上の保持器内に配置され、保持器内の隆起が分離容器内に種々の堰を形成する。装置に使用する管セットおよび種々の分離容器も開示する。
Patent JP-2001525066-A (JP)
IPC: G01N21/64
Filed: 1998-05-12
Abstract: The invention relates to a device for measuring light-activated fluorescence of at least one coating that contains a fluorescent material, and its use for measuring fluid materials which cause fluorescence-quenching in at least one of the fluorescent coatings. To activate the fluorescence, at least one first light wave guide is directed onto at least one coating applied to a support and the fluorescent light is directed at a detector by means of at least one second light wave guide, in order to determine the intensity of the fluorescent light. The end faces of the different fluorescent light wave guides are then arranged, taking into account the numerical apertures of the different light wave guides and/or with reference to at least one coating containing a fluorescent material, in such a way that a local coordination of the measurable fluorescence intensity can be attained, and that the light source(s), light wave guides and the detector(s) are lodged in a measuring head.
Patent JP-2000514884-A (JP)
IPC: D03D11/00
Filed: 1997-12-12
Abstract: An on-machine-seamable papermakers' fabric having a smooth surface and a prolonged life includes flat machine-direction yarns which define the upper and lower surfaces thereof. The fabric has two layers of cross-machine direction yarns, each of which is interwoven with the flat machine-direction yarns. Other machine-direction yarns, of round cross section, weave with the cross-machine-direction yarns in the two layers to bind the two layers together. The knuckles of these round machine-direction yarns are within the fabric with respect to the planes defined by the flat machine-direction yarns, and, and a consequence, are less susceptible to degradation by heat and abrasion. The papermakers' fabric is seamed into endless form during installation on a paper machine. At one of the two ends of the fabric, seaming loops are formed by the round machine-direction yarns. At the other of the two ends, seaming loops are formed by the flat machine-direction yarns. The seaming loops are interdigitated with one another when the two ends of the fabric are brought together during installation on the paper machine, defining a passage through which a seaming pin or pintle may be directed to join the two ends to one another.
Patent JP-2000513655-A (JP)
Title: 多目的クリーニング装置
IPC: A01K63/04
Filed: 1997-05-19
Abstract: (57)【要約】
本発明の多目的クリーニング装置は、水タンク内に上方に向かって設けられる中空のチューブ本体と、上方に開口する所定のキャンバーチューブと、空気導入チューブを通して外部のエアポンプに接続され、前記キャンバーチューブ内に設けられる発泡石と、水タンク外に設けられるコンテナと、所定の濾過材が設けられる前記コンテナの内側の天部、ならびにドレイン排出部が設けられる底部を通して連通する前記チューブ本体の前記キャンバーチューブの水排出部とを備えることを特徴とする。したがって、低コストで酸素含有率を高め、フィルタ効果が得られる。
Patent MD-20050309-A (MD)
Inventor: BOSTAN ION
IPC: F24S90/00
Filed: 2005-10-28
Abstract: Inventia se refera la instalatiile termoenergetice fara arderea combustibilului si producerea CO2, si anume la instalatiile de conversiune a energieisolare fara elemente fotovoltaice. Instalatia solara cu motor Stirling include un concentrator solar (1), fixat rigid pe un capat al unui cadru (2), pe celalalt capat fiind fixat rigid un receptor decaldura cu elemente de termoemisie a razelor solare (3), un motor Stirling (4) si un generator electric (5). Axa comuna a generatorului electric (5),a motorului Stirling (4) si a receptorului de caldura (3) trece prin centrul geometric al concentratorului solar (1). Cadrul (2) este legat articulatcu furca (7) unei platforme rotitoare (8), instalata pe un suport vertical fix (9). Pe cadrul (2) este instalat articulat un mecanism de reglare (11)a pozitiei instalatiei in plan meridional. Motorul Stirling (4) contine cel putin 3 cilindri amplasati pe circumferinta, pistoane legate cu flansa inclinata a rotii dintate centrale a unui multiplicator precesional, care transforma miscarea de translatie alternativa a pistoanelor in miscare de rotatie a rotii dintate centrale, care, in consecinta,este multiplicata si transmisa rotorului generatorului electric (5).
Patent MX-162272-A (MX)
Inventor: GOLDWASSER DAVID J
IPC: C08G18/76
Filed: 1982-09-27
Abstract: Polyurethane resins are described having high impact strength and other structural strength properties, and significantly improved resistance to deformation by heat. The properties of these materials are such as to make them comparable to engineering thermoplastics such as nylon and like materials commonly used to fabricate structural components such as automotive parts, equipment housing, sporting goods, furniture, toys, household and like consumer goods. The resins are prepared from organic polyisocyanates, an isocyanate-reactive material (polyol, polyamine, etc.) having an average functionality of at least 1.9, a Tg less than 20 DEG  C. and molecular weight of 500-20,000, and one or more low molecular weight extenders the major distinguishing feature being the markedly lower proportion by weight (2 to 25 percent) in which the isocyanate-reactive material is employed as compared with polyurethane resins conventionally prepared in the art. Depending upon the particular combination of reactants employed the polyurethanes of the invention can be thermoplastic or thermoset and can be prepared in both cellular and non-cellular form.
Patent NZ-225746-A (NZ)
Title: Process for isolating enzymatic cleavage products of proinsulin and/or one of its derivatives having a basic ph
Inventor: DORSCHUG MICHAEL
IPC: C07K19/00
Filed: 1988-08-09
Abstract: Basic proteins are isolated from protein mixtures which contain such basic proteins and which are obtained by enzymatic clevage of proinsulin and/or its derivatives of natural, semisynthetic or genetic engineering origin by ion exchanger chromatography on strongly acid cation exchangers.
Patent NZ-226580-A (NZ)
Title: Device for destruction of foam on surface of activated sludge suspension in reaction vessel
Inventor: ORDELHEIDE ROLF
IPC: B05B1/32
Filed: 1988-10-14
Abstract: An arrangement for the destruction of foam building up on a sewage surface in form of activated sludge, in which a reaction vessel holds the suspended foam. The reaction vessel has perforated plates which may be raised and lowered. The reaction vessel is furthermore provided with an inlet pipe connection for untreated sewage, and a discharge pipe for the treated suspension. The reaction vessel is closed off at its upper side by a plate member which has at least one flow-through opening. A nozzle located within an enclosure, is connected to this flow-through opening. The nozzle has a lower wall and an upper wall disposed at an acute angle relative to one another. The lower wall and the upper wall of nozzle, furthermore, have adjacent edges forming an outlet opening of the nozzles. One of the walls of the nozzle is pivotably movable relative to the other wall.
Patent NZ-227277-A (NZ)
Title: Producing whey protein concentrate rich in immunoglobulins using membrane ultrafiltration or anion exchange resin
Inventor: BOTTOMLEY ROBIN CHARLES
IPC: A23C9/146
Filed: 1988-12-09
Abstract: The present invention provides a method of producing a whey protein concentrate rich in immunoglobulins which comprises fractionating whey proteins into an immunoglobulins rich fraction and an immunoglobulins depleted fraction and concentrating at least the immunoglobulins rich fraction, characterised by either   (i) subjecting a whey, a liquid whey protein concentrate or a reconstituted whey protein concentrate powder to ultrafiltration through a membrane having a molecular weight cut-off of substantially 500,000 whereby to directly produce an immunoglobulins enriched concentrate together with fat, the permeate containing at least a major proportion of the remaining whey proteins, or (ii) subjecting whey or a liquid whey protein concentrate to the action of an anion-exchange resin to produce an effluent, the whey proteins in which contain a higher proportion of immunoglobulins than those in the original whey or whey protein concentrate and an eluate the whey protein content of which contains a depleted proportion of immunoglobulins and subjecting at least the effluent to concentration by ultrafiltration. h
Patent NZ-231777-A (NZ)
Title: Optical phase modulator; travelling wave laser with varied injection bias
Inventor: MELLIS JOHN
IPC: G02F/
Filed: 1989-12-14
Abstract: A travelling wave laser amplifier (2) is operated as a phase modulator by applying a modulation signal on the bias injection current. To increase modulation frequency response at the higher end and to minimise unwanted amplitude modulation the input optical signal and injection bias current are preferably set so that the amplifier is running under saturated gain conditions.
Patent NZ-239202-A (NZ)
Title: N-cycloalkyl (and heterocyclyl)(methyl) sulphonamide derivatives and pharmaceutical compositions
Inventor: LARDY CLAUDE
IPC: C07D233/54
Filed: 1991-07-31
Abstract: New substituted sulphonamides, their salts, complexes, esters and amides which are physiologically acceptable, denoted by the formula <IMAGE>  in which:   R1 is an aryl radical or a heterocyclic ring, optionally (poly)substituted; R2 and R3 are different; one of the two denotes W, the other is hydrogen, halogen, trifluoromethyl, alkyl, cycloalkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, acyl, thioacyl, hydroxyl, optionally (poly)substituted amine, nitro, nitrile, azide or aryl; W is a -Z-Ar-(CH2)q-A group in which A is CO2H or a group capable of being hydrolysed to CO2H, SO3H, PO3H, a heterocyclic ring, an acyl radical, an oxoalkylcarboxylic radical or a primary alcohol; q is 0,1,2,3 or 4; Ar is an aryl radical or an aromatic heterocyclic ring, optionally substituted by a radical R7; Z is oxygen, CH2 or a bond; R4-7 take simultaneously or independently the values of R2-3, except W; Y is a -(CH2)s-B-(CH2)t- group; s and t are 0,1 or 2; B is an oxygen atom, oxidised or unoxidised sulphur, optionally substituted nitrogen, a (thio)carbonyl functional group, a heterocyclic ring, an alkylene radical, an optionally substituted alkyl radical or a bond;   n is 0 or 1.   Application of these thromboxane A2 receptor antagonist compounds with a long period of activity as antithrombotic and antiasthmatic medications.
Patent NZ-239698-A (NZ)
Title: 4-(thiazol-5-yl and imidazol-5-yl) substituted 1,3-dioxane derivative, preparation and pharmaceutical compositions thereof
Inventor: FAULL ALAN WELLINGTON
IPC: A61P9/12
Filed: 1991-09-06
Abstract: The invention concerns novel 1,3-dioxane alkenoic acid derivatives of the formula I <CHEM>  wherein: n is the integer 1 or 2;  Y is methyleneoxy, vinylene or ethylene;  A<1> is (1-6C)alkylene;  R<1> is a group of the formula R<2>.A<2>-, in which: R<2> is phenyl unsubstituted or bearing up to three substituents which are independently selected from (1-6C)alkyl, (1-6C)alkoxy, (2-6C)alkanoyl (1-6C)alkylthio, (1-6C)alkylsulphonyl, halogeno, trifluoromethyl, nitro and cyano; A<2> is a direct bond to R<2> or a group of the formula -W-C(R<4>)(R<5>)-wherein W is oxygen, methylene or a direct bond to R<2>, and R<4> and R<5> are independently (1-4C)alkyl; Q is a heterocyclyl group selected from thiazol-5-yl and imidazol-5-yl, the latter being unsubstituted or bearing a (1-12C)alkyl group at the 1-position of the imidazole ring; and R<3> is hydroxy, a physiologically acceptable alcohol residue, or (1-4C)alkanesulphonamido; or a pharmaceutically acceptable salt thereof. The compounds are thromboxane A2 antagonists and inhibitors of thromboxane A2 synthase, and are useful on the treatment of a variety of diseases in which thromboxane A2 is involved, such as is ischaemic heart disease, cerebrovascular disease and peripheral vascular disease. The invention also includes processes for the manufacture and use of the compounds, and pharmaceutical compositions containing them.
Patent NZ-245046-A (NZ)
Title: Shed formation apparatus having movable heddles; method of forming shed opening in an array of yarns
Inventor: KUSTER HEINZ
IPC: D03C3/20
Filed: 1992-11-09
Abstract: A shed formation apparatus having increased flexibility and speed. The shed formation apparatus is comprised of a plurality of movable heddles which are connected to a plurality of heddle selectors by a first plurality of control leads. The heddle selectors are movably connected to a plurality of heddle selector controllers which include stoppers to retard the movement of the heddle selectors. A second plurality of control leads are attached to the heddle selectors. A repeat pattern output apparatus determines the movement of the second plurality of control leads and the attached heddle selectors, and selectively activates the stoppers.
Patent NZ-247203-A (NZ)
Title: Apparatus for automatic placement of protective corners on palletised load
Inventor: SCHERER PHILIP G
IPC: B65B13/18
Filed: 1993-03-19
Abstract: An apparatus for placing corner protectors having elongate panels meeting at right angles onto vertical corners of pallet loads having vertical sides defining vertical corner comprises a magazine to hold a supply of the corner protectors and mechanisms for removing one corner protector from the magazine, transferring the corner protector to a position where one of its panels is disposed in close proximity to a vertical side of such a load, and displacing the corner protector until its other panel engages another side at the same corner of the load. In the magazine, the corner protectors extend vertically and are nested within one another. Also, the corner protectors are guided forwardly along a supporting chute. A wheeled carriage having an upright member is mounted operatively in the chute and prevents the corner protectors from tipping backwards.
Patent NZ-253179-A (NZ)
Title: Stable formulation of omeprazole microgranules having a neutral core of sugar and starch and a layer of omeprazole in mannitol
Inventor: DEBREGEAS PATRICE
IPC: A61K47/36
Filed: 1993-06-16
Abstract: The present invention relates to a stable formulation of omeprazole microgranules containing a neutral core consisting of sugar and starch, characterized in that it contains an active layer consisting of a dilution of omeprazole in mannitol in substantially equal amounts. It also relates to a process for producing such formulations.
Patent NZ-270890-A (NZ)
Title: Use of substituted 1,8-naphthyridine derivatives for treatment of Helicobacter pylori infection and gastric or duodenal ulcers
Inventor: GIRARD ARTHUR E
IPC: A61P31/04
Filed: 1995-04-06
Abstract: The current specification discloses the use of compounds of formula depicted wherein R1 is either H or CH3 and R2 is either H or L-alanine-L-alanyl to treat Halicobacter pylori infections and gastric or duodenal ulcers.  The compounds may be optionally combined with metronidazole or a second microbial agent such as amoxicillin, tetracycline or omeprazole.
Patent NZ-279569-A (NZ)
Title: Method of manufacturing lignocellulose fibre board by first compressing to uniform density then compressing surface layers to a higher density
Inventor: LUNDGREN GORAN
IPC: B27N3/24
Filed: 1995-01-19
Abstract: PCT No. PCT/SE95/00043 Sec. 371 Date Jun. 26, 1996 Sec. 102(e) Date Jun. 26, 1996 PCT Filed Jan. 19, 1995 PCT Pub. No. WO95/20473 PCT Pub. Date Aug. 3, 1995Continuous methods for manufacturing finished board are disclosed which include disintegrating lignocellulose material prior to drying, gluing, and forming into mats, and in which the pressing of the mat into a board includes a first step in which the mat is pressed in the presence of steam in a heating medium to produce a partially pressed board having a substantially uniform density, and a second compressing step in which the outer layers of the partially pressed board are increased in density as compared to the center of the board.
Patent NZ-282634-A (NZ)
Title: Fabric formed from polyphthalamide filament
Inventor: REITHER JOHN R
IPC: D03D15/00
Filed: 1995-02-28
Abstract: A industrial fabric of monofilament of polyphthalamide having recurring units including copolymerized hexamethylene diamine and mixtures of copolymerized terephthalic acid, isophthalic acid, and adipic acid. The monofilament has excellent hydrolysis, chemical, and abrasion resistance. It is particularly useful for the cloth in the forming and pressing sections of a papermaking machine.
Patent NZ-300349-A (NZ)
Title: Centrifuge for separating fibrous monomer from blood with annular filter
Inventor: HOLM NIELS ERIK
IPC: G01N33/49
Filed: 1995-12-01
Abstract: A method and a device for separating a component, such as fibrin I from blood, by centrifugation. The method involves feeding of blood admixed an anticlotter to a first annular chamber in a device, where the annular chamber is defined by a cylindrical outer wall and a cylindrical inner wall, both walls extending coaxially about a common axis, as well as by a top wall and a bottom wall, where the top wall or the bottom wall is formed by a piston body displaceable within the first chamber. The method involves furthermore a centrifugation of the device about the said common axis followed by a resulting liquid fraction being transferred while influenced by the piston body to a second chamber defined by an outer cylindrical wall, which extends coaxially with said common axis. As a result the liquid fraction present in the second chamber is caused to be further separated by a continued centrifugation and addition of suitable compositions promoting the separation and returning of the non-utilizable portion to the first chamber. In addition, the portion of the liquid fraction remaining in the second chamber is transferred to a liquid-receiving container through a filter optionally after addition of a solvent. The portion of the liquid fraction remaining in the second chamber prior to the transfer to the liquid-receiving container is transferred to a third chamber coaxially accommodated with the other chambers, and the liquid now present in said third chamber is caused to pass through an annular filter during the centrifugation so as to enter an annular outer compartment which is adapted to be connected to the liquid-receiving member.
Patent NZ-303504-A (NZ)
Title: Merchandising bottle dispenser with flange necks of bottles supported on tracks and tracks slidably mounted to transverse supports
Inventor: SPAMER WILLIAM S
IPC: A47F7/28
Filed: 1996-02-16
Abstract: A merchandising device is designed for dispensing bottles each having an integrally formed annular neck flange. The device includes an elongate track for supporting a row of the bottles such that the bottles in the row are suspended by their neck flanges for movement along the track and are removable from the track through the front end of the track. The track includes a pair of side walls interconnected by a top wall to form a channel structure, and a C-shaped reinforcing flange provided at the front end of the track to increase the rigidity of the front end.
Patent NZ-304107-A (NZ)
Title: Use of imidazo[1,2-a]pyridine-3-acetamide derivatives for treating neuropsychiatric disorders
Inventor: BENINCASA ELENA
IPC: A61P25/16
Filed: 1996-04-02
Abstract: The imidazo[1,2-a]pyridine-3-acetamide derivatives of formula (I) are used for the treatment of Parkinson's disease, parkinsonian syndromes, extrapyramidal syndromes, obsessive-compulsive disorder and syndromes, and frontal and subcortical dementias. In formula (I): Y represents a hydrogen or halogen atom or a C1 - 4 alkyl group; A represents naphthyl or C6 H3 X1 X2, wherein each of X1 and X2 independently of one another is a hydrogen or halogen atom, a C1 - 4 alkoxy group, a C1 - 6  alkyl group or CF3, CH3S- , CH3 SO2 - or  -NO2 ; and each of R1 and R2 independently of one another represents; a hydrogen atom, a straight or branched C1 - 5  alkyl group which is unsubstituted or substituted by one or more halogen atoms, hydroxyl, -N(C1 - 4 alkyl)2, carbamoyl or C1-  4 alkoxy groups, an allyl group, a propargyl group, a C3 - 6 cycloalkyl group, a benzyl group, a phenyl group, or -NR1R2 represents a heterocyclic ring containing from 3 to 6 carbon atoms, or a C4 H4XN heterocyclic ring wherein X is O, S, CHOR' or N-R, R' being hydrogen or benzyl and R being hydrogen, a C1 - 4 alkyl group, or phenyl which is unsubstituted or substituted by methoxy or a halogen atom, provided that if Y is 6-chloro, A is not 4-chlorophenyl.
Patent NZ-330718-A (NZ)
Title: Extracellular polysaccharide produced by streptococcus thermophilus
Inventor: LEMOINE JEROME
IPC: A23L29/269
Filed: 1998-06-18
Abstract: The specification describes isolated exo-polysaccharides originating from Streptococcus thermophilus.  The polysaccharide consists of D-galactose, L-rhamnose and D-glucose in molar ratio of 3:2:1.  The polysaccharide may be used in flavour reactions and in the preparation of a food, cosmetics or pharmaceuticals, particularly those intended for inhibiting beta-galactoside specific lectins.